West Pharma CCO Cindy Reiss-Clark departs; interim lead named

WEST PHARMACEUTICAL SERVICES INC

Cindy Reiss-Clark, SVP and Chief Commercial Officer, departed effective March 7, 2025.
Interim leadership of commercial responsibilities assumed by Aileen Kinsella, Head of Proprietary Product Sales.
Company thanked Reiss-Clark for her contributions; no reason for departure disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Cindy Reiss-Clark

Senior Vice President and Chief Commercial Officer

WST · WEST PHARMACEUTICAL SERVICES INC

Effective: 2025-03-07
Filed: March 11, 2025, 7:59 PM ET

On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, Senior Vice President and Chief Commercial Officer, has departed the Company, effective the same day.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cindy Reiss-Clark departed as Senior Vice President and Chief Commercial Officer at WEST PHARMACEUTICAL SERVICES INC.

Action: departed
Role: Senior Vice President and Chief Commercial Officer

Exact text from the filing

On March 7, 2025, West Pharmaceutical Services, Inc. (the “Company”) announced that Cindy Reiss-Clark, Senior Vice President and Chief Commercial Officer, has departed the Company, effective the same day.

View on SEC.gov

WEST PHARMACEUTICAL SERVICES INC filing history →

Source: SEC EDGAR

accession 0000105770-25-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.